Exeltis USA, Inc. et al v. Lupin Ltd. et al
| Exeltis USA, Inc., Laboratorios Leon Farma, S.A., Chemo Iberica, S.A. and Chemo Research, S.L. |
| Lupin Ltd. and Lupin Pharmaceuticals, Inc. |
| 1:2022cv00434 |
| April 1, 2022 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 20, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 12
NOTICE of Appearance by David A. Bilson on behalf of Lupin Ltd., Lupin Pharmaceuticals, Inc. (Bilson, David)
|
|
Filing 11
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John)
|
|
Filing 10
ANSWER to #1 Complaint with Jury Demand and COUNTERCLAIMS against All Plaintiffs, by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) Modified on 5/19/2022 (nms).
|
|
Filing 9
STIPULATION TO EXTEND TIME for Defendant Lupin Pharmaceuticals, Inc. to answer, move or respond to Plaintiffs' Complaint (D.I. 1) to July 18, 2022 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John)
|
|
SO ORDERED, re #9 STIPULATION and Proposed Order to Extend Time to Answer, Move, or Otherwise Respond to Complaint (*Reset Answer Deadlines: Lupin Pharmaceuticals, Inc. answer due 7/18/2022). Signed by Judge Richard G. Andrews on 4/21/2022. (nms)
|
|
Filing 8
WAIVER OF SERVICE returned executed by Exeltis USA, Inc., Chemo Research, S.L., Chemo Iberica, S.A., Laboratorios Leon Farma, S.A.: For Lupin Ltd. waiver sent on 4/18/2022, answer due 7/18/2022. (Hufnal, AnnaMartina)
|
|
Pro Hac Vice Attorney Philip K Chen, Brian D. Coggio, Megan A. Chacon, and Bernard Cryan for Chemo Iberica, S.A., Chemo Research, S.L., Exeltis USA, Inc., and Laboratorios Leon Farma, S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
SO ORDERED, re #6 MOTION for Pro Hac Vice Appearance of Attorney Brian Coggio, Megan A. Chacon, Philip K. Chen and Bernard Cryan, filed by Exeltis USA, Inc., Chemo Iberica, S.A., Chemo Research, S.L., Laboratorios Leon Farma, S.A.. Signed by Judge Richard G. Andrews on 4/6/2022. (nms)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 7
SUMMONS Returned Executed by Exeltis USA, Inc., Chemo Research, S.L., Chemo Iberica, S.A., Laboratorios Leon Farma, S.A.. Lupin Pharmaceuticals, Inc. served on 4/4/2022, answer due 4/25/2022. (Hufnal, AnnaMartina)
|
|
Filing 6
MOTION for Pro Hac Vice Appearance of Attorney Brian Coggio, Megan A. Chacon, Philip K. Chen and Bernard Cryan - filed by Chemo Iberica, S.A., Chemo Research, S.L., Exeltis USA, Inc., Laboratorios Leon Farma, S.A.. (Hufnal, AnnaMartina)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Chemo Holding, S.L. for Chemo Iberica, S.A., Laboratorios Leon Farma, S.A.; Corporate Parent Laboratorios Leon Farma, S.A., Corporate Parent Laboratorios Liconsa, S.A. for Chemo Research, S.L.; Corporate Parent EX USA Holding Corp. for Exeltis USA, Inc. filed by Chemo Iberica, S.A., Chemo Research, S.L., Exeltis USA, Inc., Laboratorios Leon Farma, S.A. (apk)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,603,860 ;10,179,140 ;10,603,281 ;10,849,857 ;10,987,364. (apk)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/21/2022. Date of Expiration of Patent: 06/28/2031.Thirty Month Stay Deadline: 8/21/2024. (apk)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
|
|
Filing 1
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Lupin Ltd., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3840858.) - filed by Exeltis USA, Inc., Chemo Research, S.L., Chemo Iberica, S.A., Laboratorios Leon Farma, S.A.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet)(apk)
|
|
No Summons Issued. (apk)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
